Abstract:Synovial inflammation mainly resulting from interleukin-1 beta (IL-1β) plays a crucial role in the early and late stage of osteoarthritis. Recent progress in therapeutic gene delivery systems has led to promising strategies for local sustained target gene expression. The aim of this study was to design a nanoparticle made of chitosan (CS)/hyaluronic acid (HA)/plasmid-DNA (pDNA) encoding IL-1 receptor antagonist gene (pIL-1Ra) and furtherly use it to transfect the primary synoviocytes, and then investigate whether CS/HA/pIL-1Ra nanoparticles could make the synoviocytes overexpress functional IL-1Ra to attenuate inflammation induced by IL-1β. In this study, CS was modified with HA to generate CS/HA nanoparticles and then combined with pIL-1Ra to form CS/HA/pIL-1Ra nanoparticles. The physicochemical characteristics results showed that CS/HA nanoparticles exhibited an appropriate particle size (144.9 ± 2.8 nm) and positive zeta potential ( + 28 mV). The gel retardation assay revealed that pDNA was effectively protected and released in a sustained manner more than 15 days. Cytotoxicity results showed that CS/HA/pIL-1Ra nanoparticles had a safe range (0-80 μg/ml) for the application to synoviocytes. RT-qPCR and western blot analysis demonstrated that CS/HA/pIL-1Ra nanoparticles were able to increase IL-1Ra expression in primary synoviocytes, and reduce the mRNA and protein levels of matrix metalloproteinase-3 (MMP-3), matrix metalloproteinase-13 (MMP-13), cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) in IL-1β-induced synoviocytes. Our findings indicated that CS/HA/pIL-1Ra nanoparticles efficiently transfected synoviocytes and attenuated synovitis induced by IL-1β, which will provide a potential strategy for OA synovitis.

Biscarbamate cross-linked low molecular weight PEI for delivering IL-1 receptor antagonist gene to synoviocytes for arthritis therapy

Transfection and Cytotoxicity Studies of Novel PEI Derivative IPEI in Synovial Cells

Extraordinarily Enhanced Gene Transfection and Cellular Uptake by Aromatic Hydrophobicization to Pei25k

Efficient Gene Transfection into Mammalian Cells Mediated by Cross-linked Polyethylenimine

Biscarbamate Cross-Linked Polyethylenimine Derivative with Low Molecular Weight, Low Cytotoxicity, and High Efficiency for Gene Delivery

Inhibition of Osteoarthritis in Rats by Electroporation with Interleukin-1 Receptor Antagonist

Chitosan/hyaluronic Acid/plasmid-Dna Nanoparticles Encoding Interleukin-1 Receptor Antagonist Attenuate Inflammation in Synoviocytes Induced by Interleukin-1 Beta

Cross-linked Polyethylenimine As Potential DNA Vector for Gene Delivery with High Efficiency and Low Cytotoxicity

Cross-linked Small Polyethylenimines: While Still Nontoxic, Deliver DNA Efficiently to Mammalian Cells in Vitro and in Vivo.

Efficient and Non-Toxic Biological Response Carrier Delivering TNF-α Shrna for Gene Silencing in a Murine Model of Rheumatoid Arthritis.

Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung.

Polylysine-modified Polyethylenimine Inducing Tumor Apoptosis As an Efficient Gene Carrier

Novel poly(ethylene imine) biscarbamate conjugate as an efficient and nontoxic gene delivery system

Polyethyleneimine-functionalized iron oxide nanoparticles for systemic siRNA delivery in experimental arthritis.

Poly(β-amino Amine) Cross-Linked PEIs As Highly Efficient Gene Vectors

Alkylated low molecular polyethylenimine as a gene delivery vector

Low Molecular Weight Polyethylenimines Linked by Beta-Cyclodextrin for Gene Transfer into the Nervous System

IN VITRO EVALUATION OF INTERLEUKIN-10 GENE DELIVERY INTO DORSAL ROOT GANGLION CELLS MEDIATED BY PEI-g-MPEG

Polyethylenimine-grafted copolymer of poly(l-lysine) and poly(ethylene glycol) for gene delivery.

Biodegradable cross-linked poly(amino alcohol esters) based on LMW PEI for gene delivery.

A polymer nanoplatform with high transfection rate for the efficient gene therapy of peripheral arterial diseases